Galaxia M. Rodriguez:
ORCID: https://orcid.org/0000-0002-5366-6047
Role: ConceptualizationRole: ResourcesRole: Data curationRole: Formal analysisRole:
SupervisionRole: Funding acquisitionRole: ValidationRole: InvestigationRole: VisualizationRole:
MethodologyRole: Writing - original draftRole: Writing - review and editing
Kristianne J.C. Galpin: Role: ConceptualizationRole: ResourcesRole: Data curationRole: Formal analysisRole:
SupervisionRole: Funding acquisitionRole: ValidationRole: InvestigationRole: VisualizationRole:
MethodologyRole: Writing - original draftRole: Writing - review and editing
David P. Cook:
ORCID: https://orcid.org/0000-0001-7639-6724
Role: ResourcesRole: Data curationRole: SoftwareRole: Formal analysisRole: ValidationRole:
VisualizationRole: Methodology
Edward Yakubovich: Role: Data curationRole: SoftwareRole: Formal analysisRole: ValidationRole: Visualization
Vincent Maranda: Role: Methodology
Elizabeth A. Macdonald: Role: Methodology
Juliette Wilson-Sanchez: Role: Methodology
Anjali L. Thomas:
ORCID: https://orcid.org/0000-0001-6848-6666
Role: Methodology
Joanna E. Burdette:
ORCID: https://orcid.org/0000-0002-7271-6847
Role: Writing - review and editing
Barbara C. Vanderhyden:
ORCID: https://orcid.org/0000-0002-7644-7189
Role: SupervisionRole: Funding acquisitionRole: Writing - original draftRole: Writing
- review and editing
Journal ID (nlm-ta): Cancer Res Commun
Journal ID (iso-abbrev): Cancer Res Commun
Title:
Cancer Research Communications
Publisher:
American Association for Cancer Research
ISSN
(Electronic):
2767-9764
Publication date Collection:
June
2022
Publication date
(Electronic):
09
June
2022
Volume: 2
Issue: 6
Pages: 417-433
Affiliations
[1
]Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Ontario,
Canada.
[2
]Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario,
Canada.
[3
]Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois
at Chicago, Chicago, Illinois.
Author notes
G.M. Rodriguez and K.J.C. Galpin contributed equally to this article.
Corresponding Author: Barbara C. Vanderhyden, Cancer Therapeutics Program, Ottawa Hospital Research Institute,
501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada. Phone: 613-737-7700, ext. 70330;
E-mail:
bvanderhyden@
123456ohri.ca
Author information
Article
Publisher ID:
CRC-22-0017
DOI: 10.1158/2767-9764.CRC-22-0017
PMC ID: 9616009
PubMed ID: 36311166
SO-VID: 05868f55-956d-4c71-9687-b81e606d4589
Copyright © © 2022 The Authors; Published by the American Association for Cancer Research
License:
This open access article is distributed under the Creative Commons Attribution 4.0
International (CC BY 4.0) license.
Funded by:
http://dx.doi.org/10.13039/501100000024, Gouvernement du Canada | Canadian Institutes of Health Research (IRSC);
Award ID: PJT-156139
Award Recipient
:
Barbara C. Vanderhyden
Funded by:
http://dx.doi.org/10.13039/100000002, HHS | National Institutes of Health (NIH);
Award ID: CA240301
Award Recipient
:
Joanna E. Burdette
Funded by:
http://dx.doi.org/10.13039/501100000156, FRQ | Fonds de Recherche du Québec - Santé (FRQS);
Award Recipient
:
Galaxia M. Rodriguez
Funded by:
http://dx.doi.org/10.13039/501100000008, Gouvernement du Canada | Health Canada (Santé Canada);
Award Recipient
:
Barbara C. Vanderhyden
Funded by:
http://dx.doi.org/10.13039/501100000024, Gouvernement du Canada | Canadian Institutes of Health Research (IRSC);
Award Recipient
:
Kristianne J.C. Galpin
Funded by:
http://dx.doi.org/10.13039/501100000024, Gouvernement du Canada | Canadian Institutes of Health Research (IRSC);
Award Recipient
:
David P. Cook
Subject:
Research Article
Subject:
Gynecological Cancers
Subject:
Ovarian Cancer
Subject:
Tumor Microenvironment
Subject:
Immune Cells and the Microenvironment
Subject:
Immunology
Subject:
Tumor Immunology Animal Models
Subject:
Single Cell Technologies
Subject:
Preclinical Models
Subject:
Xenograft Models